Trials / Completed
CompletedNCT02482701
The Captivator EMR Registry
An International, Multicenter, Prospective, Post Market Registry Using a New Device for Endoscopic Resection of Early Neoplasia in Barrett's Esophagus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 291 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To confirm performance of the Captivator™ EMR device for resection of early neoplasia in Barrett's Esophagus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Captivator™ EMR | The Captivator ™ EMR Device is indicated for endoscopic mucosal resection (EMR) in the upper gastrointestinal (GI) tract. |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2017-05-01
- Completion
- 2017-06-01
- First posted
- 2015-06-26
- Last updated
- 2018-03-07
Locations
13 sites across 6 countries: United States, Belgium, Canada, Germany, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT02482701. Inclusion in this directory is not an endorsement.